Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.

Tandem Diabetes Care, Inc. TNDM has signed a multi-year collaboration agreement with the University of Virginia Center for Diabetes Technology (UVA). The partnership will focus on advancing research ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it signed a multi-year R&D collaboration agreement with the ...

Beta Bionics is commercializing innovative insulin delivery technologies, but faces challenges in achieving profitability.

Beta Bionics (BBNX), a maker of insulin delivery devices, has filed for a $100M initial public offering. While Beta Bionics ...

New research about to get underway at the University of Virginia could help make life easier for people with Type One Diabetes- by possibly developing a fully automated insulin pump.

UVA Center for Diabetes has signed an agreement to advance research on fully automated insulin delivery systems.

A new study published in the NEJM Evidence journal showed that automated insulin delivery reduced hypoglycemia in older ...

Tandem Diabetes (TNDM) announced it has signed a multi-year collaboration agreement with the University of Virginia Center for Diabetes ...

unlike the present Hybrid Closed Loop products, complements Modular Medical's easy-to-use and cost-effective MODD1 insulin pump technology. Our combined system is intended to nudge blood glucose ...